BRDG
Next report

Feb 23 2026

EPS estimate

—

Revenue estimate

—

EPS beats

8 of last 12

EPS surprise

2023: 0.0%2023: 5.6%2023: 0.0%2023: 4.8%2024: -22.2%2024: 6.3%2024: 11.8%2024: -16.7%2025: 12.5%2025: -47.1%2025: -36.4%
Nov 8 2022Aug 7 2025
ReportedEPS estEPS actualSurpriseRevenue estRevenue actualSurprise
Aug 7 2025$0.22$0.14-36.4%$98M$97M-1.1%
May 8 2025$0.17$0.09-47.1%$78M$96M+24.1%
Feb 24 2025$0.16$0.18+12.5%$82M$103M+25.7%
Nov 6 2024$0.18$0.15-16.7%$81M$102M+26.0%
Aug 6 2024$0.17$0.19+11.8%$90M$112M+23.9%
May 8 2024$0.16$0.17+6.3%$88M$116M+31.6%
Feb 21 2024$0.18$0.14-22.2%$80M$103M+28.5%
Nov 7 2023$0.21$0.22+4.8%$96M$106M+10.3%
Aug 7 2023$0.20$0.20+0.0%$97M$99M+1.7%
May 8 2023$0.18$0.19+5.6%$88M$91M+4.1%
Feb 14 2023$0.21$0.21+0.0%$77M$95M+24.1%
Nov 8 2022$0.24$0.29+20.8%$74M$110M+49.1%

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+14.54%
EPS+16.16%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027E
Revenue Avg$517M$592M
Low$517M$592M
High$517M$592M
EBITDA Avg$54M$58M
Low$50M$58M
High$58M$58M
EBIT Avg$41M$47M
Low$36M$47M
High$45M$47M
Net Income Avg$32M$37M
Low$29M$37M
High$36M$37M
EPS Avg$0.99$1.15
Low$0.88$1.15
High$1.10$1.15
Analysts (Rev / EPS)1 / 11 / 1
Quarterly
MetricQ4 2026Q1 2027Q2 2027Q3 2027Q4 2027
Revenue Avg$151M$128M$131M$134M$136M
Low$151M$128M$131M$134M$136M
High$151M$128M$131M$134M$136M
EBITDA Avg$16M$13M$17M$17M$19M
Low$16M$13M$17M$17M$19M
High$16M$13M$17M$17M$19M
EBIT Avg$13M$9M$14M$14M$16M
Low$13M$9M$14M$14M$16M
High$13M$9M$14M$14M$16M
Net Income Avg$10M$7M$11M$11M$12M
Low$10M$7M$11M$11M$12M
High$10M$7M$11M$11M$12M
EPS Avg$0.28$0.21$0.30$0.30$0.34
Low$0.28$0.21$0.30$0.30$0.34
High$0.28$0.21$0.30$0.30$0.34
Analysts (Rev / EPS)1 / 11 / 11 / 11 / 11 / 1
AI Earnings SummaryQ3 2024
Checking for summary...

Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.